PDGFRB and colonic neoplasm: In the present study, we observed that the prophylactic immunization performed to trigger PDGFRβ–specific immunotherapy in the CT26 colon cancer model only led to a minor reduction in liver metastasis compared to control animals thus suggesting that improvements in the vaccine protocol have to be envisaged for its application as single agent strategy.